Ablation - Cardiovascular Update

Shorten the Blanking Period After Atrial Fibrillation Ablation, Experts Say

DAIC

APRIL 18, 2024

Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrial fibrillation ablation, Musat et al. Early recurrence of atrial tachyarrhythmia (ERAT) is commonly seen following catheter ablation of AF, with reported incidences of up to 61% in the first three months.

Atrial Fibrillation

Atrial Fibrillation Ablation Heart Rhythm Article

Boston Scientific Receives FDA Approval for FARAPULSE Pulsed Field Ablation System

DAIC

JANUARY 31, 2024

Food and Drug Administration (FDA), has granted approval to Boston Scientific for its FARAPULSE Pulsed Field Ablation System. intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific. "The

Ablation

Ablation Atrial Fibrillation Pulmonary Anatomy

Ghrelin deletion and conditional ghrelin cell ablation increase pancreatic islet size in mice

Journal of Clinical Investigation - Cardiology

DECEMBER 15, 2023

We demonstrate that reducing ghrelin — by ghrelin gene knockout (GKO), conditional ghrelin cell ablation, or high-fat diet (HFD) feeding — was associated with increased mean islet size (up to 62%), percentage of large islets (up to 854%), and β cell cross-sectional area (up to 51%).

Ablation

Ablation Diet Obesity Diabetes

Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter

DAIC

JANUARY 8, 2024

milla1cf Mon, 01/08/2024 - 14:26 January 8, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced that the first patients have been successfully treated using its Magnetic Interventional Ablation Catheter, MAGiC. Physicians at Vilnius University.

Ablation

Ablation Innovation Electrophysiology Technology

CardioFocus to Present Data Supporting Next Generation Pulsed Field Ablation Systems at Heart Rhythm 2024

DAIC

MAY 15, 2024

a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, announced its participation at the Heart Rhythm 2024 conference, taking place in person at the Boston Convention & Exhibition Center and virtually, May 16-19, 2024. milla1cf Wed, 05/15/2024 - 19:05 May 15, 2024 — CardioFocus, Inc. ,

Heart Rhythm

Heart Rhythm Ablation Innovation Pulmonary

Colchicine Not the Answer for Recurring Arrhythmias After Ablation

Med Page Today

DECEMBER 21, 2023

(MedPage Today) -- For patients undergoing catheter ablation for atrial fibrillation (Afib), there was no signal that a brief course of colchicine reduced atrial arrhythmia recurrence or improved clinical outcomes when taken for 10 days starting.

Arrhythmia

Arrhythmia Ablation Atrial Fibrillation AFIB

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. The company now anticipates U.S. Circulation.

Atrial Fibrillation

Atrial Fibrillation Ablation Atrial Flutter Blood Clot

News from EHRA 2024: International Experts Agree on Standards for Catheter Ablation of Atrial Fibrillation

DAIC

APRIL 9, 2024

An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany. Image courtesy: European Society of Cardiology.

Atrial Fibrillation

Atrial Fibrillation Ablation Heart Rhythm Blood Clot

AI-Guidance Boosts Arrhythmia Ablation Success in Persistent Cases

Med Page Today

MAY 18, 2024

(MedPage Today) -- BOSTON -- For persistent atrial fibrillation (Afib), adding artificial intelligence guidance for ablation site selection improved success, the TAILORED trial showed. Freedom from Afib after one procedure regardless of antiarrhythmic.

Ablation

Ablation AFIB Arrhythmia Atrial Fibrillation

Ablation Bests Drugs for Ventricular Tachycardia After Heart Attack

Med Page Today

NOVEMBER 16, 2024

(MedPage Today) -- CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation improved outcomes compared with trying antiarrhythmic drugs first, the VANISH2 trial showed. Death or.

Tachycardia

Tachycardia Heart Attack Heart attacks Ablation

Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation

DAIC

FEBRUARY 2, 2024

Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Biosense Webster's zero fluoroscopy workflow is the first and only such workflow available in a radiofrequency (RF) cardiac ablation device.

Ablation

Ablation Atrial Fibrillation AFIB Heart Rhythm

Analysis: Pulsed Field Afib Ablation Superior to Thermal Methods

Med Page Today

MAY 21, 2024

(MedPage Today) -- BOSTON -- Pulsed field ablation (PFA) trials continued to accrue positive data, as reported at the Heart Rhythm Society (HRS) annual meeting. Superiority, Finally Secondary analysis of the pivotal ADVENT trial showed that.

Ablation

Ablation AFIB Heart Rhythm

FDA OKs Farapulse Pulsed Field Ablation System for Intermittent Afib

Med Page Today

JANUARY 31, 2024

(MedPage Today) -- The FDA approved the Farapulse pulsed field ablation (PFA) system for paroxysmal atrial fibrillation (Afib or AF), Boston Scientific announced on Wednesday. The device won an indication for the isolation of pulmonary veins in.

AFIB

AFIB Ablation Atrial Fibrillation Pulmonary

Ablation may be better than medication for those with dangerous heartbeat after heart attack

American Heart News - Heart News

NOVEMBER 16, 2024

Research Highlights: A new, multicenter study demonstrated that ablation treatment may be a better first option than medication for many heart attack survivors who develop abnormal electrical short circuits in their heart, which are episodes of.

Heart Attack

Heart Attack Heart attacks Ablation Research

Association between triglyceride–glucose index trajectories and radiofrequency ablation outcomes in patients with stage 3D atrial fibrillation

Cardiovascular Diabetology

APRIL 4, 2024

This study investigates the relationship between triglyceride-glucose (TyG) index trajectories and the results of ablation in patients with stage 3D atrial fibrillation (AF).

Atrial Fibrillation

Atrial Fibrillation Ablation Outcomes Research

Late-breaking Clinical Trial Results from FARADISE, adMIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment

DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Atrial Fibrillation

Atrial Fibrillation Heart Rhythm Ablation Quality of Life

Does Ejection Fraction Make or Break Afib Ablation in Heart Failure Patients?

Med Page Today

APRIL 24, 2024

(MedPage Today) -- The efficacy of catheter ablation for heart failure (HF) patients with atrial fibrillation (Afib or AF) hinged on the phenotype of disease, researchers reported based on a meta-analysis. Compared with conventional rate or rhythm.

AFIB

AFIB Heart Failure Ablation Atrial Fibrillation

First Pulsed Field Ablation Catheter Approved for Afib

Med Page Today

DECEMBER 14, 2023

(MedPage Today) -- The FDA approved the first pulsed field ablation (PFA) catheter, the PulseSelect PFA system, for the treatment of paroxysmal and persistent atrial fibrillation (Afib), Medtronic announced on Wednesday. Whereas conventional radiofrequency.

AFIB

AFIB Ablation Atrial Fibrillation

Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat Atrial Fibrillation

DAIC

DECEMBER 14, 2023

Launching the first FDA -approved PFA technology is not just a milestone; the PulseSelect PFA system is setting a new standard in safety for AF ablation with excellent efficacy and efficiency 1. In my clinical experience with the catheter, it was designed for AF ablation procedures.

Atrial Fibrillation

Atrial Fibrillation Ablation Technology Heart Failure

Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow (EGF) Mapping for use in Atrial Fibrillation Ablation

DAIC

FEBRUARY 6, 2024

EGF mapping allows physicians to detect EGF sources and is designed to individualize ablation strategies based on underlying pathophysiologic mechanisms to potentially improve outcomes. By guiding ablation therapy, [EGF mapping] can enable clinicians to provide personalized, highly targeted treatment."

Ablation

Ablation Atrial Fibrillation AFIB Pulmonary

Abbott Announces First Global Procedures in a Clinical Trial of its Volt Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

DAIC

JANUARY 18, 2024

milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heart rhythms such as atrial fibrillation (AFib).

Heart Rhythm

Heart Rhythm Ablation AFIB Chest Pain

Cost, Efficiency and Outcomes of Pulsed Field Ablation versus Thermal Ablation for Atrial Fibrillation: A Real World Study

HeartRhythm

MAY 15, 2024

With the exponential growth of catheter ablation (CA) for atrial fibrillation (AF), there is increasing interest in associated healthcare costs.

Atrial Fibrillation

Atrial Fibrillation Ablation Outcomes

Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction

JAMA Cardiology

APRIL 23, 2024

This systematic review and meta-analysis investigates the efficacy of catheter ablation compared with rate or rhythm control among patients with atrial fibrillation and heart failure.

Preserved Ejection Fraction

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation

Convergent approach to persistent atrial fibrillation ablation: long-term single-centre safety and efficacy

Frontiers in Cardiovascular Medicine

FEBRUARY 7, 2024

Methods All patients undergoing convergent PsAF ablation at our centre were retrospectively analysed. The Atricure Epi-Sense® system was used to perform surgical radiofrequency ablation of the LA posterior wall followed by endocardial ablation.

Atrial Fibrillation

Atrial Fibrillation Ablation Document Obesity

Local impedance and contact force guidance to predict successful cavotricuspid isthmus ablation with a zero-fluoroscopy approach

Frontiers in Cardiovascular Medicine

JANUARY 3, 2024

At the same time, there is growing concern regarding catheter ablation performed under fluoroscopy guidance, due to its harmful effects for both patients and practitioners. Methods We conducted a prospective observational study recruiting 50 consecutive patients who underwent CTI ablation. Ω vs. 31.2 ± 9.81 Ω, p = 0.19).

Ablation

Ablation Technology

Ablation as First-Line Treatment in Tolerated VT and LVEF >35%

American College of Cardiology

NOVEMBER 26, 2024

What are the outcomes of patients referred for ventricular tachycardia (VT) ablation according to left ventricular ejection fraction (LVEF), tolerance of VT, and acute ablation outcome?

Ablation

Ablation Tachycardia Outcomes Article

Superior Vena Cava Isolation After Pulsed-Field Ablation of the Right Superior Pulmonary Vein

HeartRhythm

NOVEMBER 7, 2024

Superior vena cava (SVC) conduction delay or isolation during right superior pulmonary vein (RSPV) ablation using thermal ablation technologies has been previously described.1,2 1,2 No reports regarding the impact of pulsed-field ablation (PFA) on the SVC exist.

Ablation

Ablation Pulmonary Technology

Atrial Fibrillation Ablation in Congenital Heart Disease: Therapeutic Challenges and Future Perspectives

Journal of the American Heart Association

JANUARY 9, 2024

Herein, we provide an overview of the current knowledge on the pathophysiology and risk factors for AF in adult congenital heart disease, with a special focus on the existing challenges in AF ablation. Emerging imaging modalities and ablation techniques might have a role to play.

Congenital Heart Disease

Congenital Heart Disease Atrial Fibrillation Congenital Heart Disease

Nitroglycerin to Ameliorate Coronary Artery Spasm During AF Ablation

American College of Cardiology

JUNE 13, 2024

What is the potential of focal pulsed field ablation (PFA) to provoke coronary spasm during cavotricuspid isthmus ablation, and does nitroglycerin use mitigate the risk of vasospasm in this setting?

Ablation

Ablation Article

The effect of an initial catheter ablation with an adjunctive ethanol infusion into the vein of Marshall on persistent atrial fibrillation

Journal of Cardiovascular Electrophysiology

JANUARY 28, 2024

Abstract Introduction Some previous studies have reported that a first-step ethanol infusion into the vein of Marshall (EIVOM) with touch-up radiofrequency (RF) ablation can facilitate mitral isthmus (MI) block and improves the ablation outcomes in persistent atrial fibrillation (PeAF) patients. 0.78, p = .006).

Atrial Fibrillation

Atrial Fibrillation Ablation Bicuspid/Mitral Tachycardia

Association between preprocedural serum potassium level and atrial fibrillation recurrence after catheter ablation

HeartRhythm

JUNE 17, 2024

The association between serum potassium and atrial fibrillation (AF) recurrence after catheter ablation remains unclear.

Atrial Fibrillation

Atrial Fibrillation Ablation

Long-term results of ablation index guided atrial fibrillation ablation: insights after 5+ years of follow-up from the MPH AF Ablation Registry

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Background Catheter ablation (CA) for symptomatic atrial fibrillation (AF) offers the best outcomes for patients. Despite the benefits of CA, a significant proportion of patients suffer a recurrence; hence, there is scope to potentially improve outcomes through technical innovations such as ablation index (AI) guidance during AF ablation.

Ablation

Ablation Atrial Fibrillation BMI Arrhythmia

Catheter ablation in patients with atrial fibrillation and dilated cardiomyopathy

Frontiers in Cardiovascular Medicine

JANUARY 16, 2024

Introduction Catheter ablation is an effective and safe strategy for treating atrial fibrillation patients. Nevertheless, studies on the long-term outcomes of catheter ablation in patients with dilated cardiomyopathy are limited. Among the catheter ablation group, 58.7% ( n = 27) had persistent atrial fibrillation.

Atrial Fibrillation

Atrial Fibrillation Cardiomyopathy Ablation Heart Failure

Pulsed field ablation procedures found safe and effective for atrial fibrillation patients

Medical Xpress - Cardiology

JULY 8, 2024

Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF), according to the largest study of its kind on this new technology, led by the Icahn School of Medicine at Mount Sinai.

Atrial Fibrillation

Atrial Fibrillation Ablation Technology

Regional Differences in the Outcomes of Catheter Ablation for Atrial Fibrillation in the United States

HeartRhythm

APRIL 8, 2024

There is insufficient data assessing the regional differences in catheter ablation outcomes for atrial fibrillation (AF) in the United States.

Atrial Fibrillation

Atrial Fibrillation Ablation Outcomes Inpatient

Pulsed Field Ablation of the Right Superior Pulmonary Vein Prevents Vagal Responses Via Anterior Right Ganglionated Plexus Modulation

HeartRhythm

JANUARY 27, 2024

Pulsed field ablation (PFA) is selective for the myocardium. Anterior-right GP ablation has been proven to effectively prevent vagal responses during radiofrequency-based PVI. However, vagal responses and reversible effects on ganglionated plexi (GP) are observed during pulmonary vein isolation (PVI).

Pulmonary

Pulmonary Ablation

Afib Ablation Delivers in First Sham-Controlled Study

Med Page Today

SEPTEMBER 2, 2024

(MedPage Today) -- LONDON -- Pulmonary vein isolation (PVI) produced real short-term improvements for people with atrial fibrillation (Afib or AF), according to the first sham-controlled trial on the subject. Continuous monitoring by implantable.

AFIB

AFIB Atrial Fibrillation Ablation Pulmonary

Mediterranean Diet After Afib Ablation: Maybe?

Med Page Today

MAY 19, 2024

(MedPage Today) -- BOSTON -- An olive oil-enhanced Mediterranean diet didn't help prevent atrial fibrillation (Afib, or AF) recurrence after ablation in the PREDIMAR randomized trial, although there was a signal for benefit in paroxysmal cases.

AFIB

AFIB Diet Ablation Atrial Fibrillation

Long-term Health-related Quality of Life and Rhythm-Outcomes of Catheter Ablation versus Antiarrhythmic Drugs in Patients with Atrial Fibrillation.

HeartRhythm

SEPTEMBER 20, 2024

Data on long-term effects of catheter ablation versus antiarrhythmic drugs (AAD) on health-related quality of life (HRQoL) and atrial fibrillation (AF) burden are limited.

Quality of Life

Quality of Life Atrial Fibrillation Ablation Outcomes

Pulsed Field Ablation to Treat Paroxysmal AF

American College of Cardiology

OCTOBER 16, 2024

What is the long-term safety and effectiveness of an integrated pulsed field ablation (PFA) system in a large United Statesâ€“based drug-refractory symptomatic paroxysmal atrial fibrillation (AF) patient population?

Ablation

Ablation Atrial Fibrillation Article

Ventricular Tachycardia Antiarrhythmics or Ablation in Structural Heart Disease 2

American College of Cardiology

NOVEMBER 16, 2024

The goal of the VANISH2 trial was to compare endocardial catheter ablation with conventional antiarrhythmic drug (AAD) therapy as a first-line treatment for infarct-related ventricular tachycardia (VT) in ischemic cardiomyopathy.

Tachycardia

Tachycardia Ablation Heart Disease Cardiomyopathy

Ablation Strategies for AF Recurrences

American College of Cardiology

OCTOBER 17, 2024

What is the comparative efficacy of two contemporary ablation strategies for patients with atrial fibrillation (AF) recurrences despite durably isolated pulmonary veins?

Ablation

Ablation Atrial Fibrillation Pulmonary Article

Association of typical atrial flutter and cavotricuspid isthmus ablation on clinical recurrence after cryoballoon ablation for atrial fibrillation

Frontiers in Cardiovascular Medicine

DECEMBER 14, 2023

This study investigated the association between concurrent typical atrial flutter and cavotricuspid isthmus (CTI) ablation and the recurrence of atrial arrhythmia. The data were obtained from a multicenter registry of cryoballoon ablation for AF ( n = 2,689). All the patients with typical atrial flutter underwent CTI ablation.

Atrial Flutter

Atrial Flutter Atrial Fibrillation Ablation Arrhythmia

Stroke and Bleeding Risks of Endocardial Ablation for Ventricular Arrhythmias

American College of Cardiology

FEBRUARY 23, 2024

What is the incidence of the embolic and bleeding complications in relation to pre- and post- periprocedure antithrombotic regimens in patients undergoing ventricular arrhythmia radiofrequency ablation (RFA)?

Arrhythmia

Arrhythmia Ablation Embolism Stroke

Shorten the Blanking Period After Atrial Fibrillation Ablation, Experts Say

Boston Scientific Receives FDA Approval for FARAPULSE Pulsed Field Ablation System

Ghrelin deletion and conditional ghrelin cell ablation increase pancreatic islet size in mice

Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter

CardioFocus to Present Data Supporting Next Generation Pulsed Field Ablation Systems at Heart Rhythm 2024

Colchicine Not the Answer for Recurring Arrhythmias After Ablation

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

News from EHRA 2024: International Experts Agree on Standards for Catheter Ablation of Atrial Fibrillation

AI-Guidance Boosts Arrhythmia Ablation Success in Persistent Cases

Ablation Bests Drugs for Ventricular Tachycardia After Heart Attack

Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation

Analysis: Pulsed Field Afib Ablation Superior to Thermal Methods

FDA OKs Farapulse Pulsed Field Ablation System for Intermittent Afib

Ablation may be better than medication for those with dangerous heartbeat after heart attack

Association between triglyceride–glucose index trajectories and radiofrequency ablation outcomes in patients with stage 3D atrial fibrillation

Late-breaking Clinical Trial Results from FARADISE, adMIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment

Does Ejection Fraction Make or Break Afib Ablation in Heart Failure Patients?

First Pulsed Field Ablation Catheter Approved for Afib

Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat Atrial Fibrillation

Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow (EGF) Mapping for use in Atrial Fibrillation Ablation

Abbott Announces First Global Procedures in a Clinical Trial of its Volt Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

Cost, Efficiency and Outcomes of Pulsed Field Ablation versus Thermal Ablation for Atrial Fibrillation: A Real World Study

Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction

Convergent approach to persistent atrial fibrillation ablation: long-term single-centre safety and efficacy

Local impedance and contact force guidance to predict successful cavotricuspid isthmus ablation with a zero-fluoroscopy approach

Ablation as First-Line Treatment in Tolerated VT and LVEF >35%

Superior Vena Cava Isolation After Pulsed-Field Ablation of the Right Superior Pulmonary Vein

Atrial Fibrillation Ablation in Congenital Heart Disease: Therapeutic Challenges and Future Perspectives

Nitroglycerin to Ameliorate Coronary Artery Spasm During AF Ablation

The effect of an initial catheter ablation with an adjunctive ethanol infusion into the vein of Marshall on persistent atrial fibrillation

Association between preprocedural serum potassium level and atrial fibrillation recurrence after catheter ablation

Long-term results of ablation index guided atrial fibrillation ablation: insights after 5+ years of follow-up from the MPH AF Ablation Registry

Catheter ablation in patients with atrial fibrillation and dilated cardiomyopathy

Pulsed field ablation procedures found safe and effective for atrial fibrillation patients

Regional Differences in the Outcomes of Catheter Ablation for Atrial Fibrillation in the United States

Pulsed Field Ablation of the Right Superior Pulmonary Vein Prevents Vagal Responses Via Anterior Right Ganglionated Plexus Modulation

Afib Ablation Delivers in First Sham-Controlled Study

Mediterranean Diet After Afib Ablation: Maybe?

Long-term Health-related Quality of Life and Rhythm-Outcomes of Catheter Ablation versus Antiarrhythmic Drugs in Patients with Atrial Fibrillation.

Pulsed Field Ablation to Treat Paroxysmal AF

Ventricular Tachycardia Antiarrhythmics or Ablation in Structural Heart Disease 2

Ablation Strategies for AF Recurrences

Association of typical atrial flutter and cavotricuspid isthmus ablation on clinical recurrence after cryoballoon ablation for atrial fibrillation

Stroke and Bleeding Risks of Endocardial Ablation for Ventricular Arrhythmias

Stay Connected